Levosimendan for calcium channel blocker poisoning in humans.
Espinoza
Tamara R
TR
Mottram
Allan R
AR
Bryant
Sean M
SM
D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000506:poisoning*; D002395:Catecholamines / Q000378:metabolism; D006439:Hemodynamics; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D006946:Hyperinsulinism / Q000628:therapy; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D014661:Vasoconstriction; D014665:Vasodilator Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000378:metabolism
D002121:Calcium Channel Blockers; D002395:Catecholamines; D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D014667:Vasopressins; D000077464:Simendan